| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 2.49e-05 | 8 | 20 | 2 | GO:0006616 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane | 3.09e-04 | 27 | 20 | 2 | GO:0006614 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 3.33e-04 | 28 | 20 | 2 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 3.33e-04 | 28 | 20 | 2 | GO:0048313 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 4.08e-04 | 31 | 20 | 2 | GO:0045048 | |
| GeneOntologyBiologicalProcess | intracellular protein transmembrane transport | 4.08e-04 | 31 | 20 | 2 | GO:0065002 | |
| GeneOntologyBiologicalProcess | cotranslational protein targeting to membrane | 4.35e-04 | 32 | 20 | 2 | GO:0006613 | |
| Domain | TRAM1 | 3.97e-06 | 3 | 22 | 2 | PF08390 | |
| Domain | TRAM1 | 3.97e-06 | 3 | 22 | 2 | IPR013599 | |
| Domain | Translocation_assoc_membrane | 3.97e-06 | 3 | 22 | 2 | IPR016447 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.99e-05 | 177 | 22 | 4 | IPR003591 | |
| Domain | LRR_TYP | 4.99e-05 | 177 | 22 | 4 | SM00369 | |
| Domain | LRR | 8.18e-05 | 201 | 22 | 4 | PS51450 | |
| Domain | LRR_1 | 1.14e-04 | 219 | 22 | 4 | PF00560 | |
| Domain | TLC | 1.57e-04 | 16 | 22 | 2 | PS50922 | |
| Domain | TLC-dom | 1.57e-04 | 16 | 22 | 2 | IPR006634 | |
| Domain | TLC | 1.57e-04 | 16 | 22 | 2 | SM00724 | |
| Domain | TRAM_LAG1_CLN8 | 1.57e-04 | 16 | 22 | 2 | PF03798 | |
| Domain | Leu-rich_rpt | 2.58e-04 | 271 | 22 | 4 | IPR001611 | |
| Domain | - | 4.90e-04 | 321 | 22 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 5.32e-04 | 328 | 22 | 4 | IPR032675 | |
| Domain | LRR_8 | 1.02e-03 | 171 | 22 | 3 | PF13855 | |
| Domain | IQ | 4.06e-03 | 81 | 22 | 2 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.98e-03 | 90 | 22 | 2 | IPR000048 | |
| Domain | IQ | 5.31e-03 | 93 | 22 | 2 | PS50096 | |
| Domain | Protein_kinase_ATP_BS | 9.59e-03 | 379 | 22 | 3 | IPR017441 | |
| Domain | PROTEIN_KINASE_ATP | 1.60e-02 | 459 | 22 | 3 | PS00107 | |
| Domain | Prot_kinase_dom | 1.90e-02 | 489 | 22 | 3 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.94e-02 | 493 | 22 | 3 | PS50011 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 25744025 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 19861416 | ||
| Pubmed | Clarifying the role of G protein signaling in HIV infection: new approaches to an old question. | 4.56e-05 | 16 | 22 | 2 | 20842205 | |
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 1.87e-04 | 32 | 22 | 2 | 37067297 | |
| Pubmed | Spatiotemporal gene expression patterns reveal molecular relatedness between retinal laminae. | 4.41e-04 | 49 | 22 | 2 | 31609468 | |
| Pubmed | 5.56e-04 | 55 | 22 | 2 | 31985874 | ||
| Pubmed | Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice. | 5.76e-04 | 56 | 22 | 2 | 30104731 | |
| GeneFamily | TLC domain containing | 2.50e-05 | 10 | 14 | 2 | 1374 | |
| GeneFamily | Solute carriers | 3.64e-02 | 395 | 14 | 2 | 752 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 2.12e-06 | 190 | 22 | 4 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.13e-05 | 148 | 22 | 3 | 438fe292d29be0206e1d9fd59ede5f8368f13665 | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 6.96e-05 | 164 | 22 | 3 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 165 | 22 | 3 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.88e-05 | 171 | 22 | 3 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 172 | 22 | 3 | d824e46c8040b0bb9235f9b8a2b35386b303caa0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 172 | 22 | 3 | 10a1d1838492b8ce6dea08844353b51571432c56 | |
| ToppCell | Adult-Immune-natural_killer_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.17e-05 | 180 | 22 | 3 | fc59e28f39e7d4fb1bcc7205202cf39224b70d7b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.63e-05 | 183 | 22 | 3 | 01c7f01498a9894920edf8243e41187cbdf90688 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 9.79e-05 | 184 | 22 | 3 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 186 | 22 | 3 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 22 | 3 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 22 | 3 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.03e-04 | 187 | 22 | 3 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 1.06e-04 | 189 | 22 | 3 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.06e-04 | 189 | 22 | 3 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 189 | 22 | 3 | 9c963f525ae765499b3e3229fead3aef018345ef | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.06e-04 | 189 | 22 | 3 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.06e-04 | 189 | 22 | 3 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-04 | 190 | 22 | 3 | 1f890be1ac8613a098b271945f25a58c3c2530ab | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 190 | 22 | 3 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-04 | 190 | 22 | 3 | d7cecf88451f736f8f3f6f4644504cf22846cd6e | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 1.08e-04 | 190 | 22 | 3 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | Adult-Immune-natural_killer_cell|Adult / Lineage, Cell type, age group and donor | 1.09e-04 | 191 | 22 | 3 | 758ec27e47d7662a5175305e98a1506c6859dbf7 | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.09e-04 | 191 | 22 | 3 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 1.13e-04 | 193 | 22 | 3 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.13e-04 | 193 | 22 | 3 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 194 | 22 | 3 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | Control-Lymphoid|Control / Disease state, Lineage and Cell class | 1.14e-04 | 194 | 22 | 3 | d5b124f15c953eeb7e8e990df44d7fa466f2b31f | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-04 | 194 | 22 | 3 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 195 | 22 | 3 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 195 | 22 | 3 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 195 | 22 | 3 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | LAM-Lymphoid-NK|LAM / Condition, Lineage and Cell class | 1.16e-04 | 195 | 22 | 3 | 229374c72acef32b0e915379bdf3c82f351940e2 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.20e-04 | 197 | 22 | 3 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.20e-04 | 197 | 22 | 3 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 198 | 22 | 3 | 1a189b2b213099505c5d871fb8aedd55a97d44e0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 198 | 22 | 3 | 716c27d2a37b5f865b9d191e1851917340b400af | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 198 | 22 | 3 | 3c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 198 | 22 | 3 | b12914c3c5b8dd628cb456cb40283c5016641872 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 198 | 22 | 3 | 9ce9b3721fb8a154667211c29e60133412134c76 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class | 1.22e-04 | 198 | 22 | 3 | 75db638278d4be2b0f406cd8871058a8352c5a86 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.23e-04 | 199 | 22 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 199 | 22 | 3 | 8a64437fecdf0b13247f2582bd2ab55ab58f8066 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 199 | 22 | 3 | ed460ff7fb82d3f0eed689d56f50d40514f74b48 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD3|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 199 | 22 | 3 | 3bf6d35e0f9be58f01a0b43cb707635595186bb0 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | b4d956067eb292cf2855c674d1eb05a5f2d988f7 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | d1cfc4ef6ae75c486427e393d98b84a2a7ec67fe | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 0a6fc7eff94e2f71af9f31a01779aafd2f4a6699 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 1db27223e307efca97502fca40ec5e4f8eea512b | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 0b65855617fb7730de48facf411e2a8980f9f780 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | c09bb5c994f098d86e873bd3f1d911b02563e6e2 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 4150170a135c37a7932bfb61acedac22dad01a3e | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.10e-04 | 53 | 22 | 2 | 52a1f2a041e3ba2b11ed753f2f57b78e68b5cc0c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.10e-04 | 53 | 22 | 2 | 5fa009c9f30c77de6cece40a47da46241f1de54c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.52e-04 | 88 | 22 | 2 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.52e-04 | 88 | 22 | 2 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.52e-04 | 88 | 22 | 2 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.71e-04 | 94 | 22 | 2 | 9664f74bc0168c92fb8a68cad628323c476f6103 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.71e-04 | 94 | 22 | 2 | c73e99890431750b74f984de5c82e33533ab708b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.71e-04 | 94 | 22 | 2 | 1bda61101f45f5c4a68453087b880fdc6d9acfca | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-03 | 108 | 22 | 2 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-03 | 108 | 22 | 2 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-03 | 112 | 22 | 2 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Cd74|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-03 | 115 | 22 | 2 | 4c7d78a246f1b44846fb959359515ef185530053 | |
| ToppCell | Mild-Myeloid-Macrophages-|Mild / Condition, Lineage, Cell class and cell subclass | 1.63e-03 | 122 | 22 | 2 | b837456a6a236add2c0005cb3ca71568d631014e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-03 | 125 | 22 | 2 | 5626eb77e542fcc87cd1fdf65f8623f3249ff9db | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.73e-03 | 126 | 22 | 2 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-03 | 126 | 22 | 2 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-03 | 126 | 22 | 2 | f582c3ed43209dca3538e60062b3edd59bf2ad6b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-03 | 128 | 22 | 2 | fbdefc29e087d36b17904c3f69302927157492a0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-03 | 130 | 22 | 2 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.84e-03 | 130 | 22 | 2 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-03 | 133 | 22 | 2 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-03 | 133 | 22 | 2 | 2ec3490cbf60152c3cece95eb566d749c9666517 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-03 | 135 | 22 | 2 | 5113bb1713f99d01103b9a99de5d80393081cf87 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-03 | 136 | 22 | 2 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.04e-03 | 137 | 22 | 2 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-03 | 139 | 22 | 2 | f1d1a51a79afdddc82e73cd29b3240e3e973db28 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-03 | 139 | 22 | 2 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | Lymphoid-T_cells_(Cd8+_T_cell)|World / shred on cell class and cell subclass (v4) | 2.10e-03 | 139 | 22 | 2 | c85f50fb536f4df6fa4dbdebe48e1ecea1df1121 | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 2.13e-03 | 140 | 22 | 2 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | TCGA-Bile_Duct-Solid_Tissue_Normal-Bile_duct_normal_tissue-Bile_duct_normal_tissue-4|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.13e-03 | 140 | 22 | 2 | 744bfab59601efb23450a9bc87bcf541f77ad6b2 | |
| ToppCell | TCGA-Bile_Duct-Solid_Tissue_Normal-Bile_duct_normal_tissue|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.13e-03 | 140 | 22 | 2 | bad9aa342bd5244263873936b55cbb95f69bdb5a | |
| ToppCell | TCGA-Bile_Duct-Solid_Tissue_Normal|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.13e-03 | 140 | 22 | 2 | 2c35c7d8b7e1101d1b74d7ce3da2364c5602c846 | |
| ToppCell | TCGA-Bile_Duct-Solid_Tissue_Normal-Bile_duct_normal_tissue-Bile_duct_normal_tissue|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.13e-03 | 140 | 22 | 2 | deb9d97f1260fe1c4ad4ec3e1ecb111d79f13058 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.16e-03 | 141 | 22 | 2 | bb77b8d12e33dc82859abd79e56a574781f815dc | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-03 | 142 | 22 | 2 | 2a9a070e7c53ac593d46c6c5f6983f07d4413501 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-03 | 142 | 22 | 2 | f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 2.19e-03 | 142 | 22 | 2 | 319812c84fad93276bf093f2ad78db02ae745bf4 | |
| ToppCell | critical-Lymphoid-NKT|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.22e-03 | 143 | 22 | 2 | dca035bfbfd1665c04076c43da8bc18a1502b9de | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-03 | 144 | 22 | 2 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-03 | 145 | 22 | 2 | a9f5a32abcf3eb2c66bd65f2521a6dd4ce56c635 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-03 | 145 | 22 | 2 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.28e-03 | 145 | 22 | 2 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-03 | 146 | 22 | 2 | deeb2c90a478deac7805e1f0d1466bf5bc42f746 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-03 | 146 | 22 | 2 | c0e1836845c083bf9d88a620da27acbfdea9fb20 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.38e-03 | 148 | 22 | 2 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-03 | 149 | 22 | 2 | 4fda987bc7bb6d1dbd41b8f1f8c1bc59613255a8 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-03 | 149 | 22 | 2 | a6c24d8f3b5f08587f0a12cd63d166b68ea000c7 | |
| Computational | Genes in the cancer module 277. | 9.04e-04 | 55 | 9 | 2 | MODULE_277 | |
| Disease | intracerebral hemorrhage | 6.33e-05 | 16 | 22 | 2 | EFO_0005669 | |
| Disease | multiple sclerosis | 8.91e-04 | 594 | 22 | 4 | MONDO_0005301 | |
| Disease | snoring measurement | 1.78e-03 | 84 | 22 | 2 | EFO_0008341 | |
| Disease | Papillary Renal Cell Carcinoma | 4.07e-03 | 128 | 22 | 2 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.07e-03 | 128 | 22 | 2 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.07e-03 | 128 | 22 | 2 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.07e-03 | 128 | 22 | 2 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.07e-03 | 128 | 22 | 2 | C1266044 | |
| Disease | ovarian neoplasm | 4.46e-03 | 134 | 22 | 2 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 4.65e-03 | 137 | 22 | 2 | C1140680 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.40e-03 | 148 | 22 | 2 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLTNHLGHTLLNLSG | 4336 | Q86UQ4 | |
| LFSILNGLHLHNLRG | 1916 | Q96M86 | |
| LLALLIQVHYHIGLN | 866 | Q68CQ1 | |
| GGLHSLQYLYLQDNH | 146 | Q86UN2 | |
| KHYLDQLNHILGILG | 231 | P28482 | |
| GQNIPHYIHILLANL | 266 | Q8NGH9 | |
| SLHLLYLGNTGLHRL | 281 | A6NIV6 | |
| NLEGLQNLHSLYLQG | 61 | Q96FV0 | |
| GLLQNLQHLALSYNA | 696 | Q6NSJ5 | |
| HNELGNIYTHGLALL | 46 | Q8N4S7 | |
| LNVNYLALGALHHYG | 756 | Q13724 | |
| LGYNGAILQALAVHL | 186 | Q9NX46 | |
| GLTLHLQHLGNNVFL | 366 | Q6T423 | |
| IPLLINYHQHNGGGL | 316 | Q08881 | |
| LHNIGYSAQHLDNLL | 2491 | Q8WXH0 | |
| ANYLFLHQLHLGVIG | 201 | Q96FL8 | |
| LNNYVLGAQLSHGHV | 151 | Q8IZF4 | |
| HITGAYLLYLNHLGL | 206 | Q8N609 | |
| HIAGAYLLNLNHLGL | 206 | Q15629 | |
| HLNCLVLLHELLNGY | 2251 | Q7Z7G8 | |
| IVNGIQLGIHLYAHG | 381 | Q8NBT3 | |
| ILYGALLGLQHLHNN | 136 | Q8WXR4 |